LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

LLY

1,052.84

+4.37%↑

JNJ

246.03

+1.46%↑

ABBV

228.33

+1.59%↑

NVS

164.74

+1.26%↑

MRK

123.15

+0.73%↑

Search

Pulse Biosciences Inc

Open

SectorHealthcare

20.37 -19.29

Overview

Share price change

24h

Current

Min

20.37

Max

25.24

Key metrics

By Trading Economics

Income

-217K

-19M

Sales

86K

86K

EPS

-0.29

Profit margin

-22,540.698

Employees

75

EBITDA

-228K

-19M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+40.06% upside

Dividends

By Dow Jones

Next Earnings

7 May 2026

Market Stats

By TradingEconomics

Market Cap

-179M

958M

Previous open

39.66

Previous close

20.37

News Sentiment

By Acuity

38%

62%

102 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Pulse Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Feb 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 Feb 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 Feb 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 Feb 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 Feb 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 Feb 2026, 23:21 UTC

Earnings

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 Feb 2026, 23:20 UTC

Earnings

Nickel Industries 2025 Operating Profit US$126.4 Million

22 Feb 2026, 23:19 UTC

Earnings

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 Feb 2026, 23:19 UTC

Earnings

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 Feb 2026, 23:18 UTC

Earnings

Nickel Industries Won't Pay a Final Dividend

22 Feb 2026, 23:16 UTC

Earnings

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 Feb 2026, 21:35 UTC

Earnings

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 Feb 2026, 21:34 UTC

Earnings

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 Feb 2026, 21:34 UTC

Earnings

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 Feb 2026, 21:33 UTC

Earnings

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 Feb 2026, 21:33 UTC

Earnings

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 Feb 2026, 21:28 UTC

Earnings

Ampol Final Dividend A$0.60/Share

22 Feb 2026, 21:28 UTC

Earnings

Ampol FY Revenue A$31.37 Billion, Down 10%

22 Feb 2026, 21:28 UTC

Earnings

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 Feb 2026, 21:28 UTC

Earnings

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 Feb 2026, 14:31 UTC

Acquisitions, Mergers, Takeovers

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 Feb 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20 Feb 2026, 23:12 UTC

Acquisitions, Mergers, Takeovers

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 Feb 2026, 22:12 UTC

Earnings

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 Feb 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 Feb 2026, 21:23 UTC

Earnings

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 Feb 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 Feb 2026, 21:01 UTC

Acquisitions, Mergers, Takeovers

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 Feb 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Peer Comparison

Price change

Pulse Biosciences Inc Forecast

Price Target

By TipRanks

40.06% upside

12 Months Forecast

Average 30 USD  40.06%

High 30 USD

Low 30 USD

Based on 2 Wall Street analysts offering 12 month price targets forPulse Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

16.59 / 17.17Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

102 / 351 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat